Hjem › Akut myelogen leukemi › California › Baldwin Park
Kliniske studier for Akut myelogen leukemi i Baldwin Park, CA
40 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Baldwin Park (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
RekruttererFase 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · 4 mi unna
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
RekruttererFase 3
- Clinical Trial Site, Duarte · 4 mi unna
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RekruttererFase 3
- City of Hope, Duarte · 4 mi unna
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekruttererFase 3
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruttererFase 2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
RekruttererFase 1
- City of Hope National Medical Center, Duarte · 4 mi unna
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- City of Hope, Duarte · 4 mi unna
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
RekruttererFase 1/2
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi unna
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
RekruttererFase 1/2
- City of Hope National Medical Center, Duarte · 4 mi unna
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Individualized AML Treatment
RekruttererObservasjonsstudie
- City of Hope Medical Center, Duarte · 4 mi unna
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi unna
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- City of Hope Medical Center, Duarte · 4 mi unna
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
RekruttererFase 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · 4 mi unna
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- City of Hope, Duarte · 4 mi unna
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi unna
A Study of Revumenib and Mezigdomide in People With Leukemia
RekruttererFase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi unna
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- City of Hope Medical Center, Duarte · 4 mi unna
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- City of Hope, Duarte · 4 mi unna
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- City of Hope Medical Center, Duarte · 4 mi unna
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
RekruttererFase 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · 4 mi unna
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
RekruttererFase 2
- City of Hope Medical Center, Duarte · 4 mi unna
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- City of Hope - Duarte, Duarte · 4 mi unna
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
RekruttererFase 1
- City of Hope Medical Center, Duarte · 4 mi unna
Study of REM-422 in Patients With AML or Higher Risk MDS
RekruttererFase 1
- City of Hope, Duarte · 4 mi unna
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
RekruttererFase 1
- City of Hope National Medical Center, Duarte · 4 mi unna
Akut myelogen leukemi-studier i andre byer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
- Washington, DC24 studier
Andre studier i Baldwin Park
- Brystkreft44 studier
- Kolorektal kreft37 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)34 studier
- Prostatakreft30 studier
- Metastatisk kreft30 studier
- Myelodysplastiske syndromer26 studier
- Eggstokkreft25 studier
- Lungekreft24 studier
- Multipelt myelom23 studier
- Mavekreft22 studier
- Akut lymfoblastisk leukemi21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.